These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33359394)

  • 1. Vasonatrin peptide, a synthetic natriuretic peptide, attenuates myocardial injury and oxidative stress in isoprenaline-induced cardiomyocyte hypertrophy.
    Chang P; Zhang X; Chen W; Zhang J; Wang J; Wang X; Yu J; Zhu X
    Peptides; 2021 Mar; 137():170474. PubMed ID: 33359394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasonatrin peptide attenuates myocardial ischemia-reperfusion injury in diabetic rats and underlying mechanisms.
    Shi Z; Fu F; Yu L; Xing W; Su F; Liang X; Tie R; Ji L; Zhu M; Yu J; Zhang H
    Am J Physiol Heart Circ Physiol; 2015 Feb; 308(4):H281-90. PubMed ID: 25485902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vasonatrin peptide attenuates the enhancement of electrically-induced intracellular calcium transient by isoproterenol in rat cardiac myocytes].
    Guo HT; Zhu MZ; Zhang RH; Bi H; Zhang B; Zhang HF; Yu J; Lu SY; Pei JM
    Sheng Li Xue Bao; 2004 Jun; 56(3):335-40. PubMed ID: 15224146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichostatin A attenuates oxidative stress-mediated myocardial injury through the FoxO3a signaling pathway.
    Guo Y; Li Z; Shi C; Li J; Yao M; Chen X
    Int J Mol Med; 2017 Oct; 40(4):999-1008. PubMed ID: 28849190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of dioscin against isoproterenol-induced cardiac hypertrophy via adjusting PKCε/ERK-mediated oxidative stress.
    Li R; Qi Y; Yuan Q; Xu L; Gao M; Xu Y; Han X; Yin L; Liu C
    Eur J Pharmacol; 2021 Sep; 907():174277. PubMed ID: 34171391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of C-type natriuretic peptide receptor by vasonatrin peptide in cardiac myocytes and fibroblasts.
    Lü SY; Zhu MZ; Wang DS; Yu J; Guo HT; Hu YZ; Wei QM
    Acta Pharmacol Sin; 2004 Apr; 25(4):424-30. PubMed ID: 15066207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protecting effects of vasonatrin peptide against carbon tetrachloride-induced liver fibrosis.
    Chen BY; Qu P; Tie R; Zhu MZ; Zhu XX; Yu J
    Regul Pept; 2010 Sep; 164(2-3):139-43. PubMed ID: 20619296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artesunate attenuates isoprenaline induced cardiac hypertrophy in rats via SIRT1 inhibiting NF-κB activation.
    Golatkar V; Bhatt LK
    Eur J Pharmacol; 2024 Aug; 977():176709. PubMed ID: 38843948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
    Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
    Dai H; Jia G; Liu X; Liu Z; Wang H
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vincristine attenuates isoprenaline-induced cardiac hypertrophy in male Wistar rats via suppression of ROS/NO/NF-қB signalling pathways.
    Asiwe JN; Ajayi AM; Ben-Azu B; Fasanmade AA
    Microvasc Res; 2024 Sep; 155():104710. PubMed ID: 38880384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
    Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
    Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
    Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R
    Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of moderate hypoxia-induced protein synthesis by vasonatrin peptide in cultured neonatal rat cardiomyocytes].
    Lu SY; Zhu MZ; Guo HT; Yu J; Wei QM
    Sheng Li Xue Bao; 2002 Feb; 54(1):7-11. PubMed ID: 11930233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin(IL)-37 attenuates isoproterenol (ISO)-induced cardiac hypertrophy by suppressing JAK2/STAT3-signaling associated inflammation and oxidative stress.
    Guo X; Wang P; Wei H; Yan J; Zhang D; Qian Y; Guo B
    Int Immunopharmacol; 2024 Dec; 142(Pt B):113134. PubMed ID: 39293311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury.
    Korkmaz S; Radovits T; Barnucz E; Hirschberg K; Neugebauer P; Loganathan S; Veres G; Páli S; Seidel B; Zöllner S; Karck M; Szabó G
    Circulation; 2009 Aug; 120(8):677-86. PubMed ID: 19667237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes.
    Liu BY; Li L; Liu GL; Ding W; Chang WG; Xu T; Ji XY; Zheng XX; Zhang J; Wang JX
    Acta Pharmacol Sin; 2021 May; 42(5):701-714. PubMed ID: 32796955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasonatrin peptide, a new regulator of adiponectin and interleukin-6 production in adipocytes.
    Chen BY; Tie R; Qu P; Zhu MZ; Zhu XX; Jin J; Yu J
    J Endocrinol Invest; 2011 Nov; 34(10):742-6. PubMed ID: 21625198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the mechanism of how vasonatrin peptide can attenuate the growth-promoting effect of hypoxia in cardiac fibroblasts].
    Yu J; Zhu MZ; Cheng BY; Lu SY; Dong MQ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2003 Feb; 19(1):8-11. PubMed ID: 21207845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasonatrin peptide, a novel protector of dopaminergic neurons against the injuries induced by n-methyl-4-phenylpyridiniums.
    Zhao HK; Chen BY; Chang R; Wang JB; Ni F; Yang L; Dong XC; Sun SH; Zhao G; Fang W; Ma QR; Wang XL; Yu J
    Peptides; 2013 Nov; 49():117-22. PubMed ID: 24055805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.